Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands

被引：0
|
作者：
Maarten J. Postma
Marie-Louise A. Heijnen
Johannes C. Jager
机构：
[1] University of Groningen,Institute for Drug Exploration/Groningen Research Institute of Pharmacy (GUIDE/GRIP)
[2] National Institute of Public Health and the Environment (Rijksinstituut voor Volksgezondheid & Milieu; RIVM),Department of Infectious Diseases Epidemiology
[3] National Institute of Public Health and the Environment,Department for Health Services Research
来源：
PharmacoEconomics | 2001年 / 19卷
关键词：
Case Fatality; Influenza Vaccination; Invasive Pneumococcal Disease; Invasive Infection; Pneumococcal Pneumonia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To assess the cost effectiveness (net costs per life year gained) of pneumococcal vaccination of elderly individuals aged 65 years and over in The Netherlands.
引用
收藏
页码：215 / 222
页数：7
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in the Netherlands
    Postma, MJ
    Heijnen, MLA
    Jager, JC
    [J]. PHARMACOECONOMICS, 2001, 19 (02) : 215 - 222
  • [2] COST-EFFECTIVENESS OF INFANT PNEUMOCOCCAL VACCINATION IN THE NETHERLANDS
    Vemer, P.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A334 - A334
  • [3] Cost-effectiveness of pneumococcal vaccination for elderly in Sweden
    Wolff, Ellen
    Storsaeter, Jann
    Ortqvist, Ake
    Naucler, Pontus
    Larsson, Sofie
    Lepp, Tiia
    Roth, Adam
    [J]. VACCINE, 2020, 38 (32) : 4988 - 4995
  • [4] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION OF ELDERLY IN GERMANY
    Kuhlmann, A.
    Treskova, M.
    Ultsch, B.
    Weidemann, F.
    Wichmann, O.
    Falkenhorst, G.
    von der Schulenburg, Graf J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A584 - A584
  • [5] Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
    Mangen, Marie-Josee J.
    Rozenbaum, Mark H.
    Huijts, Susanne M.
    van Werkhoven, Cornelis H.
    Postma, Douwe F.
    Atwood, Mark
    van Deursen, Anna M. M.
    van der Ende, Arie
    Grobbee, Diederick E.
    Sanders, Elisabeth A. M.
    Sato, Reiko
    Verheij, Theo J. M.
    Vissink, Conrad E.
    Bonten, Marc J. M.
    de Wit, G. Ardine
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (05) : 1407 - 1416
  • [6] Cost-effectiveness of vaccination against pneumococcal pneumonia in the Netherlands
    Baltussen, RMPM
    Ament, AJHA
    Leidl, RM
    VanFurth, R
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 1997, 7 (02): : 153 - 161
  • [7] Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice
    Zeevat, F.
    van der Schans, J.
    Boersma, W. G.
    Boersma, C.
    Postma, M. J.
    [J]. VACCINE, 2019, 37 (43) : 6282 - 6284
  • [8] COST-EFFECTIVENESS ANALYSIS ON ELDERLY PNEUMOCOCCAL VACCINATION IN THE NETHERLANDS: CHALLENGING THE DUTCH HEALTH COUNCIL'S ADVICE
    Zeevat, F.
    Boersma, W. G.
    van der Schans, J.
    Boersma, C.
    Postma, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S650 - S650
  • [9] Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination in at risk adults and elderly in Turkey
    Akin, Levent
    Kaya, Mehmet
    Altinel, Serdar
    Durand, Laure
    [J]. HUMAN VACCINES, 2011, 7 (04): : 441 - 450
  • [10] Cost-Effectiveness Analysis of Pneumococcal Vaccination of Adults and Elderly Persons in Belgium
    Diana De Graeve
    Geert Lombaert
    Herman Goossens
    [J]. PharmacoEconomics, 2000, 17 : 591 - 601
12345